Now online at AIDS Treatment News:

*** Tipranavir (Aptivus): Approval Cautiously Recommended
A new protease inhibitor active against most HIV that is resistant to
other protease inhibitors is likely to be approved in the U.S. soon,
after an 11-3 vote of an advisory committee.
Full article: http://www.aidsnews.org/2005/06/tipranavir-fda.html

*** ADAP Status Now: What You Can Do
This short review of the current state of the AIDS Drug Assistance
Program tells how you can get involved.
Full article: http://www.aidsnews.org/2005/06/adap-now.html

*** Medicaid: Out-of-Pocket Expenses and Access to Care
A 27-page report by the Kaiser Family Foundation examined 13
different studies showing how increased out-of-pocket costs keep people
out of care.
Full article: http://www.aidsnews.org/2005/06/medicaid-access.html

*** Lexiva: Blood Levels Not Lowered When Taken Simultaneously with
Nexium
A study suggested that the two drugs might be used together, without
lowering the blood level of Lexiva. But the timing of the doses may be
critical.
Full article: http://www.aidsnews.org/2005/06/lexiva-nexium.html

*** New Conference for Frontline Clinicians, September 15 - 18
Ten government agencies are organizing a four-day clinical conference
for physicians, nurses, and other healthcare professionals involved in
HIV treatment.
Full article: http://www.aidsnews.org/2005/06/conference-us.html

*** Medical Innovation Prize Fund: New Idea in Drug Development
This proposal, now introduced in Congress as HR 417, would replace
current drug marketing with system better designed to reward effective
innovation. All drugs would be treated as generics immediately when
approved by the FDA, and patent holders would be rewarded from a $60
billion a year award fund for innovations that actually led to better
health.
Full article: http://www.aidsnews.org/2005/06/innovation-fund.html

*** Medical Innovation and Patent Gridlock
Is today's sheer multitude of biological patents (especially on
genetics of human beings or human pathogens) killing medical innovation
-- in addition to generating prohibitive prices for vital medical care?
Full article: http://www.aidsnews.org/2005/06/patent-gridlock.html

--
John S James
AIDS Treatment News
www.aidsnews.org